RankingsPricing
  1. US-listed companies
  2. QIAGEN N.V.
  3. Financials
  4. Cash and cash equivalents

QIAGEN N.V.QGEN

Market cap
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 2024664-0.68%
Dec 31, 2023668-8.57%
Dec 31, 2022731-17.02%
Dec 31, 2021881+47.25%
Dec 31, 2020598-4.99%
Dec 31, 2019629-45.70%
Dec 31, 20181,159+76.23%
Dec 31, 2017658+49.76%
Dec 31, 2016439+51.44%
Dec 31, 2015290-26.14%
Dec 31, 2014393+18.88%
Dec 31, 2013330-16.17%
Dec 31, 2012394+78.19%
Dec 31, 2011221-73.31%
Dec 31, 2010828

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)